[CLINICAL STUDY OF THE OINTMENT KALIXAN].
D000152:Acne Vulgaris; D000293:Adolescent; D000818:Animals; D000900:Anti-Bacterial Agents; D002056:Burns; D002648:Child; D004485:Eczema; D005499:Folliculitis; D005667:Furunculosis; D005853:Geriatrics; D006801:Humans; D006854:Hydrocortisone; D006967:Hypersensitivity; D007169:Impetigo; D007223:Infant; D007239:Infections; D007612:Kanamycin; D007871:Leg Ulcer; D009824:Ointments; D010226:Parabens; D014946:Wound Infection
D000900:Anti-Bacterial Agents; D009824:Ointments; D010226:Parabens; D007612:Kanamycin; C015358:methylparaben; D006854:Hydrocortisone
ACNE; ADOLESCENCE; ANTIBIOTICS; BURNS; CHILD; ECZEMA; FOLLICULITIS; FURUNCULOSIS; GERIATRICS; HYDROCORTISONE, TOPICAL; HYPERSENSITIVITY; IMPETIGO; INFANT; INFECTION; KANAMYCIN; LEG ULCER; METHYLPARABEN; WOUND INFECTION
ETUDE CLINIQUE DE LA POMMADE KALIXAN.